Trusted by:

clients clients clients clients clients clients clients clients clients clients
Newswise: Widespread disparities exist in treating advanced cancers
Released: 4-Sep-2024 11:05 AM EDT
Widespread disparities exist in treating advanced cancers
UT Southwestern Medical Center

A study led by researchers at UT Southwestern Medical Center reveals significant disparities across the country in the use of immunotherapy for patients with advanced kidney and bladder cancers.

Newswise: 1920_gettyimages-1411827337.jpg?10000
Released: 4-Sep-2024 11:05 AM EDT
Immune Cells Prevent Lung Healing After Viral Infection
Cedars-Sinai

Investigators involved in a multicenter study co-led by Cedars-Sinai discovered a pathway by which immune cells prevent the lungs’ protective barrier from healing after viral infections like COVID-19. The findings, published in Nature, may lead to new therapeutic treatment options.

Released: 4-Sep-2024 11:05 AM EDT
WashU scientists uncover hidden source of snow melt: dark brown carbon
Washington University in St. Louis

Researchers at Washington University in St. Louis are first to quantify the effect of dark brown carbon on snow melt.

Newswise:Video Embedded alma-detects-hallmark-wiggle-of-gravitational-instability-in-planet-forming-disk
VIDEO
Released: 4-Sep-2024 11:00 AM EDT
ALMA Detects Hallmark “Wiggle” of Gravitational Instability in Planet-Forming Disk
National Radio Astronomy Observatory

Traditionally, planet formation has been described as a “bottom-up” process, as dust grains gradually collect into bigger conglomerations over tens of millions of years: from microns, to centimeters, to meters, to kilometers.

Released: 4-Sep-2024 11:00 AM EDT
Moffitt Researchers Reveal Key LAG3 Mechanisms That Could Transform Cancer Immunotherapy
Moffitt Cancer Center

Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins involved in this process is Lymphocyte Activation Gene-3 (LAG3), which suppresses the antitumor immune response.

1-Sep-2024 11:00 AM EDT
Novel immunotherapy improves recovery from spinal cord injury
Washington University in St. Louis

WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune cells. Mice given the treatment had improved recovery from injuries, demonstrating potential for developing the therapy for people.

Newswise:Video Embedded a-new-artificial-intelligence-tool-for-cancer
VIDEO
29-Aug-2024 5:05 PM EDT
A New Artificial Intelligence Tool for Cancer
Harvard Medical School

The new approach marks a major step forward in the design of AI tools to support clinical decisions in cancer diagnosis, therapy. The model uses features of a tumor’s microenvironment to forecast how a patient might respond to therapy and to help inform individualized treatments.

Newswise: ‘Nowhere Near Done’ — UAlbany Physicists Hail Latest in Dark Matter Hunt
Released: 4-Sep-2024 10:30 AM EDT
‘Nowhere Near Done’ — UAlbany Physicists Hail Latest in Dark Matter Hunt
University at Albany, State University of New York

Physicists at the University at Albany hail the latest progress in the hunt for direct evidence of dark matter — believed to be a massive-but-so-far-invisible building block to the universe.

Released: 4-Sep-2024 10:15 AM EDT
Radiation oncology research and clinical trial results to be featured at ASTRO’s Annual Meeting in Washington
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) announced today the seven studies to be highlighted in the 2024 ASTRO Annual Meeting press program. Researchers will discuss their findings in news briefings held September 30 and October 1 at the Walter E. Washington Convention Center in Washington, D.C. and via live webcast.

Released: 4-Sep-2024 10:05 AM EDT
Allergan Aesthetics and University Lab Partners Announce NovoThelium as the Winner of the Golden Ticket Pitch Competition
University Lab Partners

University Lab Partners (ULP) is proud to announce NovoThelium as the winner of the 2nd annual Golden Ticket Pitch Competition for aesthetic startups, sponsored by Allergan Aesthetics, an AbbVie company.


close
2.736